BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 14606048)

  • 1. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of neurofibromatosis type 1].
    Lozada Y; Alvarez-Valiente H; Argüelles M
    Rev Neurol; 1998 Nov; 27(159):792-5. PubMed ID: 9859153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
    Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
    Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
    Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
    Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurofibromatosis type 1: a survey of 195 patients].
    Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
    Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
    Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
    Buteică E; Stoicescu I; Burada F; Stănoiu B
    Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lisch nodules. Markers for a non-invasive diagnosis in Recklinghausen neurofibromatosis].
    Crişan M; Talu S; Florea M; Coprean D; Cosgarea R; Crişan D
    Oftalmologia; 2008; 52(4):56-61. PubMed ID: 19354164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
    Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
    Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.
    Lammert M; Friedman JM; Kluwe L; Mautner VF
    Arch Dermatol; 2005 Jan; 141(1):71-4. PubMed ID: 15655144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of clinical features in neurofibromatosis 1 (NF1).
    Szudek J; Birch P; Riccardi VM; Evans DG; Friedman JM
    Genet Epidemiol; 2000 Dec; 19(4):429-39. PubMed ID: 11108651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
    Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.
    Wolkenstein P; Rodriguez D; Ferkal S; Gravier H; Buret V; Algans N; Simeoni MC; Bastuji-Garin S
    Br J Dermatol; 2009 Apr; 160(4):844-8. PubMed ID: 19067713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofibromatosis type 1 in children--with special consideration of ophthalmologic symptoms].
    Kósa E; Csákváry V
    Orv Hetil; 2004 Feb; 145(9):473-8. PubMed ID: 15077479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
    Odebode TO; Afolayan EA; Adigun IA; Daramola OO
    Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.